Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Investigation of preanalytical variables impacting pathogen cell-free DNA in blood and urine.

Murugesan K, Hogan CA, Palmer Z, Reeve B, Theron G, Andama A, Somoskovi A, Steadman A, Madan D, Andrews J, Croda J, Sahoo MK, Cattamanchi A, Pinsky BA, Banaei N.

J Clin Microbiol. 2019 Sep 11. pii: JCM.00782-19. doi: 10.1128/JCM.00782-19. [Epub ahead of print]

2.

Improving the cascade of global tuberculosis care: moving from the "what" to the "how" of quality improvement.

Agins BD, Ikeda DJ, Reid MJA, Goosby E, Pai M, Cattamanchi A.

Lancet Infect Dis. 2019 Aug 22. pii: S1473-3099(19)30420-7. doi: 10.1016/S1473-3099(19)30420-7. [Epub ahead of print] Review.

PMID:
31447305
3.

Home-based tuberculosis contact investigation in Uganda: a household randomised trial.

Davis JL, Turimumahoro P, Meyer AJ, Ayakaka I, Ochom E, Ggita J, Mark D, Babirye D, Okello DA, Mugabe F, Fair E, Vittinghoff E, Armstrong-Hough M, Dowdy D, Cattamanchi A, Haberer JE, Katamba A.

ERJ Open Res. 2019 Jul 29;5(3). pii: 00112-2019. doi: 10.1183/23120541.00112-2019. eCollection 2019 Jul.

4.

Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses.

Kendall EA, Kamoga C, Kitonsa PJ, Nalutaaya A, Salvatore PP, Robsky K, Nakasolya O, Mukiibi J, Isooba D, Cattamanchi A, Kato-Maeda M, Katamba A, Dowdy DW.

PLoS One. 2019 Jul 24;14(7):e0220251. doi: 10.1371/journal.pone.0220251. eCollection 2019.

5.

Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening.

Alipanah N, Shete PB, Nguyen H, Nguyen NV, Luu L, Pham T, Nguyen H, Nguyen P, Tran MC, Pham N, Phan H, Phillips PPJ, Cattamanchi A, Nahid P.

Diagnostics (Basel). 2019 May 30;9(2). pii: E56. doi: 10.3390/diagnostics9020056.

6.

Outcomes of empiric treatment for pediatric tuberculosis, Kampala, Uganda, 2010-2015.

Wobudeya E, Jaganath D, Sekadde MP, Nsangi B, Haq H, Cattamanchi A.

BMC Public Health. 2019 Apr 29;19(1):446. doi: 10.1186/s12889-019-6821-2.

7.

Seasonality of childhood tuberculosis cases in Kampala, Uganda, 2010-2015.

Jaganath D, Wobudeya E, Sekadde MP, Nsangi B, Haq H, Cattamanchi A.

PLoS One. 2019 Apr 9;14(4):e0214555. doi: 10.1371/journal.pone.0214555. eCollection 2019.

8.

Outlook for tuberculosis elimination in California: An individual-based stochastic model.

Goodell AJ, Shete PB, Vreman R, McCabe D, Porco TC, Barry PM, Flood J, Marks SM, Hill A, Cattamanchi A, Kahn JG.

PLoS One. 2019 Apr 9;14(4):e0214532. doi: 10.1371/journal.pone.0214532. eCollection 2019.

9.

Ultrasensitive detection of lipoarabinomannan with plasmonic grating biosensors in clinical samples of HIV negative patients with tuberculosis.

Wood A, Barizuddin S, Darr CM, Mathai CJ, Ball A, Minch K, Somoskovi A, Hamasur B, Connelly JT, Weigl B, Andama A, Cattamanchi A, Gangopadhyay K, Bok S, Gangopadhyay S.

PLoS One. 2019 Mar 26;14(3):e0214161. doi: 10.1371/journal.pone.0214161. eCollection 2019.

10.

Building a tuberculosis-free world: The Lancet Commission on tuberculosis.

Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP.

Lancet. 2019 Mar 30;393(10178):1331-1384. doi: 10.1016/S0140-6736(19)30024-8. Epub 2019 Mar 20. Review. No abstract available.

PMID:
30904263
11.

Diagnostic accuracy of TB-LAMP for pulmonary tuberculosis: a systematic review and meta-analysis.

Shete PB, Farr K, Strnad L, Gray CM, Cattamanchi A.

BMC Infect Dis. 2019 Mar 19;19(1):268. doi: 10.1186/s12879-019-3881-y.

12.

Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.

Chaisson LH, Semitala FC, Asege L, Mwebe S, Katende J, Nakaye M, Andama AO, Marquez C, Atuhumuza E, Kamya M, Cattamanchi A, Yoon C.

AIDS. 2019 Apr 1;33(5):895-902. doi: 10.1097/QAD.0000000000002130.

PMID:
30649057
13.

Reply to Parker: Implications of Tuberculosis Sputum Culture Test Sensitivity on Accuracy of Other Diagnostic Modalities.

Yoon C, Semitala FC, Cattamanchi A.

Am J Respir Crit Care Med. 2019 Mar 1;199(5):665. doi: 10.1164/rccm.201811-2218LE. No abstract available.

PMID:
30525900
14.

A Novel, 5-Transcript, Whole-blood Gene-expression Signature for Tuberculosis Screening Among People Living With Human Immunodeficiency Virus.

Rajan JV, Semitala FC, Mehta T, Seielstad M, Montalvo L, Andama A, Asege L, Nakaye M, Katende J, Mwebe S, Kamya MR, Yoon C, Cattamanchi A.

Clin Infect Dis. 2019 Jun 18;69(1):77-83. doi: 10.1093/cid/ciy835.

PMID:
30462176
15.

Diagnostic performance of blood inflammatory markers for tuberculosis screening in people living with HIV.

Farr K, Ravindran R, Strnad L, Chang E, Chaisson LH, Yoon C, Worodria W, Andama A, Ayakaka I, Bbosa Nalwanga P, Byanyima P, Kalema N, Kaswabuli S, Katagira W, Aman KD, Musisi E, Tumwine NW, Sanyu I, Ssebunya R, Davis JL, Huang L, Khan IH, Cattamanchi A.

PLoS One. 2018 Oct 23;13(10):e0206119. doi: 10.1371/journal.pone.0206119. eCollection 2018.

16.

Effectiveness-implementation of COPD case finding and self-management action plans in low- and middle-income countries: global excellence in COPD outcomes (GECo) study protocol.

Siddharthan T, Pollard SL, Quaderi SA, Mirelman AJ, Cárdenas MK, Kirenga B, Rykiel NA, Miranda JJ, Shrestha L, Chandyo RK, Cattamanchi A, Michie S, Barber J, Checkley W, Hurst JR; GECo Study Investigators.

Trials. 2018 Oct 19;19(1):571. doi: 10.1186/s13063-018-2909-8.

17.

Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.

Keshavjee S, Amanullah F, Cattamanchi A, Chaisson R, Dobos KM, Fox GJ, Gendelman HE, Gordon R, Hesseling A, Le Van H, Kampmann B, Kana B, Khuller G, Lewinsohn DM, Lewinsohn DA, Lin PL, Lu LL, Maartens G, Owen A, Protopopova M, Rengarajan J, Rubin E, Salgame P, Schurr E, Seddon JA, Swindells S, Tobin DM, Udwadia Z, Walzl G, Srinivasan S, Rustomjee R, Nahid P.

Am J Respir Crit Care Med. 2019 Mar 1;199(5):564-571. doi: 10.1164/rccm.201806-1053PP. No abstract available.

18.

Quality of care in childhood tuberculosis diagnosis at primary care clinics in Kampala, Uganda.

Kizito S, Katamba A, Marquez C, Turimumahoro P, Ayakaka I, Davis JL, Cattamanchi A.

Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1196-1202. doi: 10.5588/ijtld.18.0043.

19.

'Something so hard': a mixed-methods study of home sputum collection for tuberculosis contact investigation in Uganda.

Armstrong-Hough M, Ggita J, Turimumahoro P, Meyer AJ, Ochom E, Dowdy D, Cattamanchi A, Katamba A, Davis JL.

Int J Tuberc Lung Dis. 2018 Oct 1;22(10):1152-1159. doi: 10.5588/ijtld.18.0129.

20.

Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.

Yoon C, Semitala FC, Asege L, Katende J, Mwebe S, Andama AO, Atuhumuza E, Nakaye M, Armstrong DT, Dowdy DW, McCulloch CE, Kamya M, Cattamanchi A.

Am J Respir Crit Care Med. 2019 Mar 1;199(5):643-650. doi: 10.1164/rccm.201803-0490OC.

PMID:
30192649
21.

Association of Rapid Molecular Testing With Duration of Respiratory Isolation for Patients With Possible Tuberculosis in a US Hospital.

Chaisson LH, Duong D, Cattamanchi A, Roemer M, Handley MA, Schillinger D, Sur M, Pham P, Lin MA, Goldman LE, Quan J, Perez S, Healy M, Higashi J, Winston L, Haller B, Luetkemeyer AF, Davis JL.

JAMA Intern Med. 2018 Oct 1;178(10):1380-1388. doi: 10.1001/jamainternmed.2018.3638.

PMID:
30178007
22.

Whole-genome sequencing and single nucleotide polymorphisms in multidrug-resistant clinical isolates of Mycobacterium tuberculosis from the Philippines.

Roa MB, Tablizo FA, Morado EKD, Cunanan LF, Uy IDC, Ng KCS, Manalastas-Cantos KG, Reyes JM, Ganchua SKC, Ang CF, Kato-Maeda M, Cattamanchi A, Karaoz U, Destura RV, Lluisma AO.

J Glob Antimicrob Resist. 2018 Dec;15:239-245. doi: 10.1016/j.jgar.2018.08.009. Epub 2018 Aug 18.

23.

Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda.

Ggita JM, Ojok C, Meyer AJ, Farr K, Shete PB, Ochom E, Turimumahoro P, Babirye D, Mark D, Dowdy D, Ackerman S, Armstrong-Hough M, Nalugwa T, Ayakaka I, Moore D, Haberer JE, Cattamanchi A, Katamba A, Davis JL.

Int J Tuberc Lung Dis. 2018 May 1;22(5):530-536. doi: 10.5588/ijtld.17.0521.

24.

Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.

Fregonese F, Ahuja SD, Akkerman OW, Arakaki-Sanchez D, Ayakaka I, Baghaei P, Bang D, Bastos M, Benedetti A, Bonnet M, Cattamanchi A, Cegielski P, Chien JY, Cox H, Dedicoat M, Erkens C, Escalante P, Falzon D, Garcia-Prats AJ, Gegia M, Gillespie SH, Glynn JR, Goldberg S, Griffith D, Jacobson KR, Johnston JC, Jones-López EC, Khan A, Koh WJ, Kritski A, Lan ZY, Lee JH, Li PZ, Maciel EL, Galliez RM, Merle CSC, Munang M, Narendran G, Nguyen VN, Nunn A, Ohkado A, Park JS, Phillips PPJ, Ponnuraja C, Reves R, Romanowski K, Seung K, Schaaf HS, Skrahina A, Soolingen DV, Tabarsi P, Trajman A, Trieu L, Banurekha VV, Viiklepp P, Wang JY, Yoshiyama T, Menzies D.

Lancet Respir Med. 2018 Apr;6(4):265-275. doi: 10.1016/S2213-2600(18)30078-X. Erratum in: Lancet Respir Med. 2018 Apr 18;:.

PMID:
29595509
25.

The sixth vital sign: HIV status assessment and severe illness triage in Uganda.

Cummings MJ, Goldberg E, Mwaka S, Kabajaasi O, Vittinghoff E, Katamba A, Cattamanchi A, Kenya-Mugisha N, Davis JL, Jacob ST.

Public Health Action. 2017 Dec 21;7(4):245-250. doi: 10.5588/pha.17.0045. Epub 2017 Nov 13.

26.

Predictors and short-term outcomes of recurrent pulmonary tuberculosis, Uganda: a cohort study.

Kalema N, Lindan C, Glidden D, Yoo SD, Katamba A, Alfred A, Katagira W, Byanyima P, Musisi E, Kaswabuli S, Ingvar S, Zawedde J, Yoon C, Ayakaka I, Davis JL, Huang L, Worodria W, Cattamanchi A.

S Afr Respir J. 2017;23(4):106-112.

27.

Unusual Radiographic Presentation of Pneumocystis Pneumonia in a Patient with AIDS.

Block BL, Mehta T, Ortiz GM, Ferris SP, Vu TH, Huang L, Cattamanchi A.

Case Rep Infect Dis. 2017;2017:3183525. doi: 10.1155/2017/3183525. Epub 2017 Dec 7.

28.

Selecting and Improving Quasi-Experimental Designs in Effectiveness and Implementation Research.

Handley MA, Lyles CR, McCulloch C, Cattamanchi A.

Annu Rev Public Health. 2018 Apr 1;39:5-25. doi: 10.1146/annurev-publhealth-040617-014128. Epub 2018 Jan 12. Review.

PMID:
29328873
29.

Brief Report: "Give Me Some Time": Facilitators of and Barriers to Uptake of Home-Based HIV Testing During Household Contact Investigation for Tuberculosis in Kampala, Uganda.

Armstrong-Hough M, Ggita J, Ayakaka I, Dowdy D, Cattamanchi A, Haberer JE, Katamba A, Davis JL.

J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):400-404. doi: 10.1097/QAI.0000000000001617.

30.

A complex intervention to improve implementation of World Health Organization guidelines for diagnosis of severe illness in low-income settings: a quasi-experimental study from Uganda.

Cummings MJ, Goldberg E, Mwaka S, Kabajaasi O, Vittinghoff E, Cattamanchi A, Katamba A, Kenya-Mugisha N, Jacob ST, Davis JL.

Implement Sci. 2017 Nov 6;12(1):126. doi: 10.1186/s13012-017-0654-0.

31.

Drop-out from the tuberculosis contact investigation cascade in a routine public health setting in urban Uganda: A prospective, multi-center study.

Armstrong-Hough M, Turimumahoro P, Meyer AJ, Ochom E, Babirye D, Ayakaka I, Mark D, Ggita J, Cattamanchi A, Dowdy D, Mugabe F, Fair E, Haberer JE, Katamba A, Davis JL.

PLoS One. 2017 Nov 6;12(11):e0187145. doi: 10.1371/journal.pone.0187145. eCollection 2017.

32.

Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study.

Yoon C, Semitala FC, Atuhumuza E, Katende J, Mwebe S, Asege L, Armstrong DT, Andama AO, Dowdy DW, Davis JL, Huang L, Kamya M, Cattamanchi A.

Lancet Infect Dis. 2017 Dec;17(12):1285-1292. doi: 10.1016/S1473-3099(17)30488-7. Epub 2017 Aug 25.

33.

Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis.

Yoon C, Chaisson LH, Patel SM, Allen IE, Drain PK, Wilson D, Cattamanchi A.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1013-1019. doi: 10.5588/ijtld.17.0078. Review.

34.

Evaluation of antibody responses to panels of M. tuberculosis antigens as a screening tool for active tuberculosis in Uganda.

Shete PB, Ravindran R, Chang E, Worodria W, Chaisson LH, Andama A, Davis JL, Luciw PA, Huang L, Khan IH, Cattamanchi A.

PLoS One. 2017 Aug 2;12(8):e0180122. doi: 10.1371/journal.pone.0180122. eCollection 2017.

35.

Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda.

Meyer AJ, Atuheire C, Worodria W, Kizito S, Katamba A, Sanyu I, Andama A, Ayakaka I, Cattamanchi A, Bwanga F, Huang L, Davis JL.

PLoS One. 2017 Jul 7;12(7):e0180572. doi: 10.1371/journal.pone.0180572. eCollection 2017.

36.

Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy.

Shete PB, Nalugwa T, Farr K, Ojok C, Nantale M, Howlett P, Haguma P, Ochom E, Mugabe F, Joloba M, Chaisson LH, Dowdy DW, Moore D, Davis JL, Katamba A, Cattamanchi A.

Int J Tuberc Lung Dis. 2017 Jul 1;21(7):746-752. doi: 10.5588/ijtld.16.0699.

37.

Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults.

Murray M, Cattamanchi A, Denkinger C, Van't Hoog A, Pai M, Dowdy D.

BMJ Glob Health. 2016 Sep 28;1(2):e000064. doi: 10.1136/bmjgh-2016-000064. eCollection 2016.

38.

Early postoperative management after lung transplantation: Results of an international survey.

King CS, Valentine V, Cattamanchi A, Franco-Palacios D, Shlobin OA, Brown AW, Singh R, Bogar L, Nathan SD.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12985. Epub 2017 May 29.

PMID:
28425132
39.

Identifying barriers to and facilitators of tuberculosis contact investigation in Kampala, Uganda: a behavioral approach.

Ayakaka I, Ackerman S, Ggita JM, Kajubi P, Dowdy D, Haberer JE, Fair E, Hopewell P, Handley MA, Cattamanchi A, Katamba A, Davis JL.

Implement Sci. 2017 Mar 9;12(1):33. doi: 10.1186/s13012-017-0561-4.

40.

Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.

Alipanah N, Cattamanchi A, Menzies R, Hopewell PC, Chaisson RE, Nahid P.

Int J Tuberc Lung Dis. 2016 Nov;20(11):1522-1528. Review.

PMID:
27776595
41.

An Official American Thoracic Society Research Statement: Implementation Science in Pulmonary, Critical Care, and Sleep Medicine.

Weiss CH, Krishnan JA, Au DH, Bender BG, Carson SS, Cattamanchi A, Cloutier MM, Cooke CR, Erickson K, George M, Gerald JK, Gerald LB, Goss CH, Gould MK, Hyzy R, Kahn JM, Mittman BS, Mosesón EM, Mularski RA, Parthasarathy S, Patel SR, Rand CS, Redeker NS, Reiss TF, Riekert KA, Rubenfeld GD, Tate JA, Wilson KC, Thomson CC; ATS Ad Hoc Committee on Implementation Science.

Am J Respir Crit Care Med. 2016 Oct 15;194(8):1015-1025.

42.

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A.

Clin Infect Dis. 2016 Oct 1;63(7):853-67. doi: 10.1093/cid/ciw566.

43.

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.

Blount RJ, Tran MC, Everett CK, Cattamanchi A, Metcalfe JZ, Connor D, Miller CR, Grinsdale J, Higashi J, Nahid P.

BMC Public Health. 2016 Aug 25;16(1):875. doi: 10.1186/s12889-016-3519-6.

44.

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A.

Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10.

45.

Higher cost of implementing Xpert(®) MTB/RIF in Ugandan peripheral settings: implications for cost-effectiveness.

Hsiang E, Little KM, Haguma P, Hanrahan CF, Katamba A, Cattamanchi A, Davis JL, Vassall A, Dowdy D.

Int J Tuberc Lung Dis. 2016 Sep;20(9):1212-8. doi: 10.5588/ijtld.16.0200.

46.

Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model.

Moses MW, Zwerling A, Cattamanchi A, Denkinger CM, Banaei N, Kik SV, Metcalfe J, Pai M, Dowdy D.

Sci Rep. 2016 Jul 29;6:30781. doi: 10.1038/srep30781.

47.

Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis.

Hanrahan CF, Haguma P, Ochom E, Kinera I, Cobelens F, Cattamanchi A, Davis L, Katamba A, Dowdy D.

Open Forum Infect Dis. 2016 May 12;3(2):ofw068. doi: 10.1093/ofid/ofw068. eCollection 2016 Mar.

48.

Empiric TB Treatment of Severely Ill Patients With HIV and Presumed Pulmonary TB Improves Survival.

Katagira W, Walter ND, Den Boon S, Kalema N, Ayakaka I, Vittinghoff E, Worodria W, Cattamanchi A, Huang L, Davis JL.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):297-303. doi: 10.1097/QAI.0000000000000970.

49.

Strategies for implementing implementation science: a methodological overview.

Handley MA, Gorukanti A, Cattamanchi A.

Emerg Med J. 2016 Sep;33(9):660-4. doi: 10.1136/emermed-2015-205461. Epub 2016 Feb 18. Review.

PMID:
26893401
50.

Blood Transcriptional Biomarkers for Active Tuberculosis among Patients in the United States: a Case-Control Study with Systematic Cross-Classifier Evaluation.

Walter ND, Miller MA, Vasquez J, Weiner M, Chapman A, Engle M, Higgins M, Quinones AM, Rosselli V, Canono E, Yoon C, Cattamanchi A, Davis JL, Phang T, Stearman RS, Datta G, Garcia BJ, Daley CL, Strong M, Kechris K, Fingerlin TE, Reves R, Geraci MW.

J Clin Microbiol. 2016 Feb;54(2):274-82. doi: 10.1128/JCM.01990-15. Epub 2015 Nov 18.

Supplemental Content

Loading ...
Support Center